Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-233681
Filing Date
2025-10-07
Accepted
2025-10-07 17:24:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d91027d424b3.htm 424B3 32901
2 GRAPHIC g91027g1007001721111.jpg GRAPHIC 3189
  Complete submission text file 0001193125-25-233681.txt   38728
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-279773 | Film No.: 251380682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)